January 23, 2018
Rose
Bio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail Partners.
from MobiHealthNews http://ift.tt/2E3bkVW
January 23, 2018
Rose
MobiHealthNews
No comments
Related Posts:
How big pharma is using AI for drug discovery, clinical trials, and more- Post-hurricane telemedicine use spiked, but largely provided routine care
- In study, smartphone-based reader detects infections with clinical-level accuracy
- CMS overhauls meaningful use EHR program, removes redundancies
- Philips adds American Well telemedicine into uGrow baby-tracking app
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment